Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ · Manufacturing · Biological products, (no diagnostic substances)
ABOS price, last 12 months
Key stats
- Previous close
- $0.1944
- Open
- $0.1944
- Day range
- $0.1740 – $0.1966
- 52-week range
- $0.1600 – $3.60
- Volume
- 2.2M
- Avg volume (20 days)
- 7.5M
- Market cap
- $15.5M
Performance
Technicals and fundamentals
About Acumen Pharmaceuticals, Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.
- Sector
- Manufacturing
- Industry
- Biological products, (no diagnostic substances)
- Listed on
- NASDAQ
- Market cap
- $15.5M